期刊文献+

肝肾综合征的发生机制和治疗进展 被引量:3

下载PDF
导出
作者 王宇 贾继东
出处 《肝脏》 2006年第1期45-47,共3页 Chinese Hepatology
  • 相关文献

参考文献14

  • 1Arroyo V,Gines P,Gerbes A,et al.Definition and dignostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology,1996,23:164-176.
  • 2王宇,崔炎,贾继东,欧晓娟,钱林学,张福奎,尹珊珊,赵新颜,王宝恩.38例肝肾综合征患者的临床分析[J].中华肝脏病杂志,2003,11(10):628-628. 被引量:8
  • 3Gines P,Guevara M,Arroyo V,et al.Hepatorenal syndrome.Lancet,2003,362:1819-1827.
  • 4Guevara M,Gines P,Fernandez-Esparrach G,et al.Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.Hepatology,1998,27:35-41.
  • 5Morean R,Durand F,Poynard T,et al.Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:A retrospective multicenter study.Gastroenterology,2002,122:923-930.
  • 6Solanki P,Chawla A,Grag R,et al.Beneficial effects of tedipressin in hepatorenal syndrome:A prospective,randomized placebo-controlled clinical trial.J Gastroenterol Hepatol,2003,18:152-156.
  • 7Angeli P,Volpin R,Gerunda G,et al.Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.Hepatology,1999,29:1690-1698.
  • 8Wong F,Pantea L,Sniderman K.Midodrine,octreotide,albumin,and TIPS in selectd patients with cirrhosis and type 1 hepatorenal syndrome.Hepatology,2004,40:55-64.
  • 9Duvoux C,Zanditenas D,Hezode C,et al,Effects of noradrenaline and albumin in patients with type 1 hepatorenal syndrome:A pilot study.Hepatology,2002,36:374-380.
  • 10Brensing KA,Textor J,Perz J,et al.Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome:A phase study.Gut,2000,47:288-295.

二级参考文献4

  • 1Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology, 1996, 23: 164-166.
  • 2Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg, 1964, 1: 1-85.
  • 3Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology, 2001, 6: 1242-1251.
  • 4Guevara M. Treatment of hepatorenal syndrome. J Gastroenterol Hepatol, 2003, 26: 270-274.

共引文献7

同被引文献21

  • 1杨政,沈红.肝肾综合征的诊断与治疗[J].国外医学(泌尿系统分册),2005,25(4):533-539. 被引量:5
  • 2罗筱莲,斯崇文.肝肾综合征的发病机制和治疗的进展[J].国际流行病学传染病学杂志,2006,33(1):31-33. 被引量:4
  • 3龙鑫,周清.肝硬化并发肝肾综合征危险因素探讨[J].现代医药卫生,2006,22(10):1511-1512. 被引量:1
  • 4徐学康.肝脏病继发肾损害[A].钱桐荪主编.肾脏病学:第3版[C].北京:华夏出版社,2001.477.
  • 5[8]Boyer TD,Haskal ZJ.American association for the study of liver diseases.The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension[J].Hepatology,2005,41:386-400.
  • 6[1]Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Internationa Ascites Club[J].Hepatology,1996,23(1):164-176.
  • 7[5]Cines P,Guevara M,Arroyo V,et al.Hepatorenal syndrome[J].Lancet,2003,362:1819-1827.
  • 8Arroyo V,Gines P,Gerbes AL,et al.Definition and diagnosticcriteria of refractory ascites and hepatorenal syndrome in cirrhosis[J].Hepatology,1996,23(1):164-76.
  • 9王德炳译.Sabiston DC著.克氏外科学[M].第1版.北京:人民卫生出版社,2000.946.
  • 10李明宏,朱迎春,熊宇辉,韩家峰,李世刚.肝肾综合征19例分析[J].中国误诊学杂志,2008,8(19):4716-4716. 被引量:3

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部